Public SEC Form D records
Biotech Growth Form D filings - August 2026
This page lists the 11 matching Form D filings FormDFlow has indexed and tagged from public SEC EDGAR records for Biotech-tagged issuers at a FormDFlow-inferred Growth stage in August 2026 - a filtered subset, not every matching Form D filed, and not a ranked, curated, or recommended selection. FormDFlow surfaces public-disclosure data from SEC EDGAR. Nothing here is investment advice.
- Filings
- 11
- Issuers
- 10
- Combined disclosed
- $1.5B
Directory links
Filing records
11 crawlable filing links in this facet.
- Epicrispr Biotechnologies, Inc.August 26, 2026 / Reg D 506(b) / CA$212.8M
- Ensysce Biosciences, Inc.August 20, 2026 / Reg D 506(b) / CA$77.2M
- EXUMA Biotech Corp.August 20, 2026 / Reg D 506(b) / FL$70.0M
- Georgiamune, Inc.August 17, 2026 / Reg D 506(b) / MD$131.9M
- Abcuro, Inc.August 13, 2026 / Reg D 506(b) / MA$176.5M
- Entera Bio Ltd.August 12, 2026 / Reg D 506(b)$275.0M
- Claris Biotherapeutics, Inc.August 12, 2026 / Reg D 506(b) / CA$121.5M
- Claris Biotherapeutics, Inc.August 7, 2026 / Reg D 506(b) / CA$121.5M
- Jasper Therapeutics, Inc.August 5, 2026 / Reg D 506(b) / CA$132.0M
- Integrated Biosciences, Inc.August 5, 2026 / Reg D 506(b) / CA$100.0M
- Theradaptive, Inc.August 4, 2026 / Reg D 506(b) / MD$77.9M